Leptospirosis Registry - LeptoScope

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

Leptospirosis is a worldwide zoonotic diseases caused by pathogenic Leptospira spp. Human are accidental hosts, who acquired infections after exposition to animal urine, contaminated water or soil, infected tissue. Incidence of invasive leptospirosis disease causing acute kidney injury, acute respiratory distress syndrome (ARDS), myocarditis, hepatic dysfunction, hemorrhage and multi-organ failure, is globally increasing and there have been frequent outbreak situation throughout the world. Due to increasing outbreak situations and globally chances in species distributions, a worldwide surveillance in epidemiology and species distribution is urgently needed. The objective of the Leptospirosis Registry - LeptoScope is to overcome the lack knowledge on epidemiology, clinical course, prognostic factors and molecular characteristics for invasive leptospirosis disease.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:

• Cultural, serological, molecular or histological evidence of invasive leptospirosis diseases

• Clinical signs of disseminated leptospirosis disease without cultural, serological, molecular or histological evidence

• Case controls: Matching procedures for controls: Particularly, case controls will be included at the same hospitals that conduced cases based on matching of demographics, underlying diseases and duration of hospitalization (i.e. one control per case, both in the same hospital).

Locations
Other Locations
Germany
University Hospital of Cologne
RECRUITING
Cologne
Contact Information
Primary
Felix Köhler, MD
felix.koehler@uk-koeln.de
+4922147897222
Backup
Felix Köhler, MD
kidneyinfection@uk-koeln.de
Time Frame
Start Date: 2020-03-04
Estimated Completion Date: 2030-12
Participants
Target number of participants: 200
Treatments
Leptospirosis group
Patients with cultural, serological, molecular or histological evidence and clinical evidence of invasive leptospirosis disease.
Control group
Controls will be included at the same hospitals that conduced cases based on matching of demographics, underlying diseases and duration of hospitalization (i.e. one control per case, both in the same hospital)
Sponsors
Leads: University of Cologne

This content was sourced from clinicaltrials.gov